期刊文献+

脑星形细胞瘤CyclinD1、P21^(WAF1/CIP1)和Survivin关系的探讨

Expression of the CyclinD1、P21^(WAF1/CIP1) and Survivin Gene in Human Astrocytoma and Their Correlation
下载PDF
导出
摘要 目的探讨CyclinD1、P21WAF1/CIP1和Survivin与脑星形细胞瘤的相关性。方法采用ElivisionTMplus免疫组化方法,检测10例正常脑组织、60例脑星形细胞瘤中CyclinD1、P21WAF1/CIP1和Survivin的表达情况。结果在正常脑组织和脑星形细胞瘤Ⅰ级、Ⅱ级、Ⅲ级、Ⅳ级中的阳性表达情况:(1)CyclinD1阳性表达率分别为:20.00%(2/10)、25.00%(4/16)、43.75%(7/16)、50.00%(7/14)、71.43%(10/14),其表达与病理分级呈显著正相关(r=0.357,P<0.01);(2)P21WAF1/CIP1的阳性表达率分别为:0(0/10)、81.25%(13/16)、62.50%(10/16)、42.86%(6/14)、27.27%(3/14),其表达与病理分级呈显著负相关(r=-0.548,P<0.001);(3)Survivin的阳性表达率分别为:0(0/10)、56.25%(9/16)、68.75%(11/16)、92.86%(13/14)、100.00%(14/14),其表达与病理分级呈显著正相关(r=0.539,P<0.005);(4)CyclinD1表达阳性的28例中,P21WAF1/CIP1阳性表达11例,阳性率39.29%(11/28),Cy-clinD1表达阴性的32例中,P21WAF1/CIP1阳性表达21例,阳性率65.63%(21/32),两者呈负相关(r=-0.362,P<0.02);(5)Survivin表达阳性的47例中CyclinD1阳性表达27例,阳性率57.45%(27/47),Survivin表达阴性的13例中CyclinD1阳性表达1例,阳性率7.69%(1/13),两者呈显著正相关(r=0.411,P<0.005);(6)P21WAF1/CIP1表达阳性的32例中survivin阳性表达20例,阳性率62.50%(20/32),P21WAF1/CIP1表达阴性的28例中Survivin阳性表达27例,阳性率96.43%(27/28),两者呈显著负相关(r=-0.411,P<0.005)。结论(1)CyclinD1过表达、P21WAF1/CIP1表达减弱或消失以及Survivin的高表达与脑星形细胞瘤的发生、发展有关;(2)联合检测三者在一定程度上反映脑星形细胞瘤的生物学行为。 Objective To discuss the dependability of CyclinD1. P21^WAF1/CIP1 and Survivin in human astrocompass. Methods ElivisionTMplus immunohistochemical staining method was used to detect the expression of CyclinD1. P21^WAF1/CIP1 Survivin in 60 human astrocytoma. Results The expression status in normal brain tissue and astrocytoma of grade Ⅰ .grade Ⅱ .grade Ⅲ and grade Ⅳ,(1) The CyclinD1 positive ratios were 20. 00% (2/10), 25. 00% (4/16), 43. 75% (7/16), 50. 00% (7/14), 71. 43% (10/14), there was significant positive correlation difference between four grades(r=0. 357,P〈0.01). (2)The P21^WAF1/CIP1 positive ratios were 0(0/10),81.25%(13/16),62.50%(10/16) ,42.86%(6/14),27.27%(3/14) ,there was significant negative correlation difference between four grades (r = - 0. 548, P〈 0. 001). (3) The Survivin positive ratios were 0(0/10),56.25%(9/16),68.75%(11/16),92.86%(13/14),100.00%(14/14), there was significant positive correlation difference between four grades(r=0. 539, P〈0. 005). (4)In 28 example positive expression of CyclinD1, there were 11 examples showing positive expression of P21^WAF1/CIP1 , the positive ratio was 39.29%(11/28) ,and in 32 example negative expression of Cy- clinD1, there were 21 examples showing positive expression of P21^WAF1/CIP1 , the positive ratio was 65. 63%(21/32), there was negative correlation difference between CyclinD1 and P21^WAF1/CIP1 (r=-0. 362,P〈0.02). (5)In 47 example positive expression of Survivin ,there were 27 examples showing positive expression of CyclinD1, the positive ratio was 57.45 % (27/47), and in 13 examples showing negative expression of Survivin, there are 1 example showint positive expression of CyclinD1, the positive ratio was 7.69% (1/13), there was significant positive correlation difference between CyclinD1 and Survivin(r= 0. 411, P〈0. 005). (6) In 32 examples showing positive expression of P21^WAF1/CIP1 , there were 20 examples
出处 《江西医学院学报》 CAS 2008年第6期47-51,共5页 Acta Academiae Medicinae Jiangxi
基金 江西省教育厅科学技术研究项目(200677)
关键词 脑星形细胞瘤CyclinD1、P21^WAF1/CIP1 SURVIVIN 免疫组化 human astrocytoma CyclinD1 P21^WAF1/CIP1 Survivin immunohistochemistry
  • 相关文献

参考文献19

  • 1Kleihus P,Ohgakj H. Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors[J]. Toxicol Pathol, 2000,28:164- 170. 被引量:1
  • 2Ambrosini G, Adida C, Ahieri D C. A Novel Antiapoptosis Gene, Surviving, Expressed in Cancer and Lymphoma[J]. Nature Med,1997,3(8) :917-921. 被引量:1
  • 3Li Y J, Hoang Xuan K,Zhou X P,et al. Analysis of the p21 Gene in Gliomas[J]. J Neurooncol, 1998,40 (2) : 107-111. 被引量:1
  • 4Fujii M, Ishiguro R, Yamashita T, et al. CyelinD1 Amplification Correlates with Early Recurrence of Squamous Cell Carcinoma of the Tongue[J]. Cancer Lett,2001,172(2) : 187-192. 被引量:1
  • 5Khoo M L, Ezzat S, Freeman J L, et al. CyclinD1 Protein Expression Predicts Metastatic Behavior in Thyroid Papillary Microcarcinomas but is Not Associated with Gene Amplification [J]. J Clin Endocrinol Metab,2002,87(4) : 1810-1813. 被引量:1
  • 6Nakamura T, Ide H, Eguchi R, et al. Concomitant Analysis of P16/INK4, CyclinD1, and Retinoblastoma Protein Expression in Esophageal Squamoos Cell Eareinoma[J]. Hepatogastroenlerology,2003,50(53) :1321-1326. 被引量:1
  • 7Zhang Y Z,Chen S Y,Chen C J,et al. Polymorphisms in CyclinD1 Gene and Hepatocellular Carcinoma[J]. Mol Carcinog, 2002,33(2) : 125-129. 被引量:1
  • 8Burn K L, Ueki K, J hung S L, et al. Molecular Genetic Correlates of p16, edk4 and PRb Immunohisto Chemistry in Glioblastomas[J]. Neuropathol Exp Neurol, 1998,57 : 122-126. 被引量:1
  • 9姚雪峰,赵洪洋,朱贤立,刘绍春.人脑胶质瘤CDK4、CyclinD1和P16基因蛋白表达的免疫组织化学研究[J].中国组织化学与细胞化学杂志,2000,9(2):164-167. 被引量:7
  • 10Harada K, Kurisu K, SadatomoT, et al. Growth Inhibition of Human Glioma Cells by Transfection2induced p21 and Its Effects on Telomerase Activity [J]. J Neuroon2col, 2000,47 (1) :39-46. 被引量:1

二级参考文献8

  • 1Li Y J,J Neurooncol,1998年,40卷,2期,107页 被引量:1
  • 2Gartenhasus R B,Proc Nat Acad Sci SUA,1996年,93卷,2期,265页 被引量:1
  • 3Gao X,Oncogene,1995年,11卷,8期,1395页 被引量:1
  • 4Zhang T,Cancer Res,1997年,55期,169页 被引量:1
  • 5He J,Cancer Res,1995年,55期,4833页 被引量:1
  • 6Nishikawa R,Cancer Res,1995年,55期,1941页 被引量:1
  • 7Sgambato A,Carcinogenesis,1995年,16卷,2193页 被引量:1
  • 8Kamb A,Science,1994年,265期,415页 被引量:1

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部